about
Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in PigsCan heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue?Monocyte Chemotactic Protein-1-Interleukin-6-Osteopontin Pathway of Intra-Aneurysmal Tissue Healing.How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure.The role of transforming growth factor (TGF)-β in the infarcted myocardium.The extracellular matrix in myocardial injury, repair, and remodeling.Therapeutic hypothermia in ST elevation myocardial infarction (STEMI): a long way to go.Fibroblast-Extracellular Matrix Interactions in Tissue FibrosisThe long noncoding RNA Wisper controls cardiac fibrosis and remodeling.Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism.ER Protein Quality Control and the Unfolded Protein Response in the Heart.Fibroblasts and the extracellular matrix in right ventricular disease.Pretreatment with fish oil attenuates heart ischaemia consequences in rats.Guidelines for Experimental Models of Myocardial Ischemia and Infarction.Mechanisms of Fibroblast Activation in the Remodeling Myocardium.Specific Cell (Re-)Programming: Approaches and Perspectives.Assessment of the fate of myocardial necrosis by serial myocardial perfusion imaging.Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2.Identification of Potential Molecular Mechanisms and Candidate Genes Involved in The Acute Phase of Myocardial Infarction.Integration of Metabonomics and Transcriptomics Reveals the Therapeutic Effects and Mechanisms of Baoyuan Decoction for Myocardial Ischemia.Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction.Cerebral blood flow alteration following acute myocardial infarction in mice
P2860
Q36230443-E369BE86-9906-496D-8450-821B2CE857F5Q38846401-DE284F22-B78A-4054-B994-CD516DAAB2D4Q38908341-E272F1FF-D3B4-4B4E-AC33-65BEB0EBA46EQ38974621-2FBCA6CB-6025-40A8-A8ED-5C7AC43D105FQ39195639-52A9F72D-F7E2-433B-9B17-A530938AD510Q39265526-CCEAE091-397A-4C15-9CB5-033ED6674EFDQ39275058-A87465B9-968D-421D-B7CB-94D25D78A05CQ41112823-FA8C33A5-17B6-4418-89A4-1D100EC8F5C6Q41151245-01456279-DD8E-4758-904D-7B9D17221FFCQ42379056-2556CCD5-B5CF-48C0-A0B7-B457CA1B503FQ47122036-D40A3C74-2D0B-4467-ACB0-9613070255ADQ47659541-F10DB459-C0E7-4914-8BDF-D2325E989443Q47731267-F6749E1F-3E2F-4C08-A30B-445CB3743E8DQ48114484-A5B4FB57-6758-45DA-8721-1CD635B78DAEQ49917885-82C4AFFF-9384-4BF9-8DCB-8C32CF351254Q50066226-55ABB35C-AD33-4A2A-9668-80FF67255F4CQ50085975-CDD0BB9B-4260-4B28-ACE1-330B2B146705Q50957185-7E262406-5D61-487A-A4D3-A0ACAC0C34ACQ51816888-EE7495DC-CCB8-4957-9061-DC97933361D0Q52632607-7866C3A4-EED5-4A07-AE56-D85A292EC7A3Q52663632-CF99C97C-6470-4674-B59B-9889410836AEQ54977712-B124D2F0-F2F2-4E26-9515-ADB27B431365Q55017834-26E905C9-48BE-4AA4-8976-A6356A444027Q55501361-C8546715-637F-46BE-8F7F-EFCA3DE337EAQ58763909-553022D4-A689-4A8F-BE14-6375387EFEFA
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pathophysiology of Myocardial Infarction.
@en
type
label
Pathophysiology of Myocardial Infarction.
@en
prefLabel
Pathophysiology of Myocardial Infarction.
@en
P2860
P356
P1476
Pathophysiology of Myocardial Infarction.
@en
P2093
Nikolaos G Frangogiannis
P2860
P304
P356
10.1002/CPHY.C150006
P577
2015-09-20T00:00:00Z